Discrete choice experiment reveals factors influencing gastroenterologist decisions in ulcerative colitis, indicating complexity in treatment approaches.
Introduction: As the number of advanced therapies for moderately to severely active ulcerative colitis (UC) increases, it is necessary to understand the factors driving gastroenterologist (GE) choice in escalating patients (pts) from conventional to advanced therapy.
No takes yet. Share an insight, caveat, or question.
Schreiber et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: